ArticlePharmaceutics2025

Pharmacodynamic-Driven Sequence-Dependent Synergy Effects in Pemetrexed-Osimertinib Combination Against Non-Small Cell Lung Cancer (NSCLC): Optimizing Synergy Through Sequential Interval.

Kuan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.